期刊文献+

基质细胞衍生因子-1介入治疗股骨头坏死的实验研究 被引量:2

Treatment of femoral head necrosis with transplantation of stromal cell-derived factor-1: an experimental study
下载PDF
导出
摘要 目的探讨基质细胞衍生因子-1(SDF-1)治疗股骨头坏死的机制和疗效。方法选用日本大耳白兔30只,制成激素性股骨头坏死模型后,随机分为3组。A组为对照组;B组为髓心减压+生理盐水治疗组;C组为髓心减压+SDF-1治疗组。各组动物均于治疗后8周处死,处死后分别进行股骨头骨密度测定及组织病理观察。结果SDF-1治疗后8周,骨密度明显增高,病理组织学表现血管数目增多,空骨陷窝减少。SDF-1治疗后显示股骨头修复效果明显。结论髓芯减压SDF-1移植治疗股骨头缺血性坏死效果明显,具有较广的临床应用前景。 Objective To discuss the therapeutic mechanism and efficacy of stromal cell-derived factor-1 (SDF-1) in the treatment of femoral head necrosis. Methods Experimental models of hydrocortisone- induced femoral head necrosis were established in 30 Japanese rabbits, which were randomly and equally divided into three groups. Group A was regarded as control group, group B received marrow core decompression and saline injection treatment and group C underwent marrow core decompression and SDF-1 transplantation. Eight weeks after the procedure all the survival rabbits (n = 27) were sacrificed, and the specimens were sent for the measuring of bone mineral density and for histopathologic examination. Results Eight weeks after the treatment, the bone mineral density of rabbits in group C was significantly increased. Pathologically, in SDF-1 treated rabbits the amounts of the blood vessels and osteoblast cells were obviously increased while the empty bone lacunae were markedly decreased. Conclusion Transplantation of stromal cell-derived factor-1 together with marrow core decompression is very effective for the treatment of femoral head necrosis and this technique has showed a vast and bright prospect in clinical practice.
出处 《介入放射学杂志》 CSCD 北大核心 2009年第4期294-296,共3页 Journal of Interventional Radiology
基金 黑龙江省科学自然基金会(D200560)
关键词 股骨头坏死 缺血性 基质细胞衍生因子-1 髓芯减压 femoral head necrosis, avascular stromal cell-derived factor-1 marrow core decompression
  • 相关文献

参考文献9

  • 1周强,石国华,杨柳,许建中,李起鸿,谭祖键,戴刚.复合多孔生物材料在股骨头坏死模型中诱导成骨的观察[J].中华外科杂志,2002,40(6):458-461. 被引量:17
  • 2Mont MA, Jone SLC, Einhorn TA, et al . Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors [J ]. Clin Orthop, 1998, (355) (suppl) : 314 - 325.
  • 3Misra P, Lebeche D, Ly H, et al. Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1 alpha[J]. J Nucl Med, 2008,49:963 - 966.
  • 4Schober A, Knarren S, Lietz M, et al. Crucial role of stromal cell-derivedfactor-lalpha in neointima formation after vascular injury in apolipoprotein E-deficient mice[J]. Circulation, 2003, 108:2491 - 2497.
  • 5Yamaguchi J, Kusano KF, Masuo O, et al.Stromal cell-derived factor-1 effects on exvivo expanded endothelial progenitor cell recruitment for ischemic neovaseularization [J]. Circulation, 2003, 107: 1322- 1388.
  • 6Hiasa K, Ishibashi M, Ohtan i K, et al. Gene transfer of stromal cell-derived factor-1 alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway [J]. Circulation, 2004, 109, 2454 - 2461.
  • 7Reddy K, Zhou Z, Jia SF, et al. Stromal cell-derived factor-1 stimulates vaseulogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor [J]. Int J Cancer, 2008, 15, 123: 831- 837.
  • 8Nomura S, Ishii K, Inami N, et al. Alpha 4-integrin-positive microvesieles and SDF-1 in peripheral blood stem cell harvest [J]. Bone Marrow Transplant, 2008, 41 : 1071 - 1072.
  • 9Olive M, Mellad JA, Behran LE, et al. p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/ CXCR4 axis in mice[J]. J Clin Invest, 2008, 118: 2050 - 2061.

二级参考文献5

共引文献16

同被引文献33

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部